 Home > Biochemistry News > Biotechnology News > Ke Yang's team released a new version of the risk diagnosis model for early screening of esophageal malignant lesions in the Chinese population

Ke Yang's team released a new version of the risk diagnosis model for early screening of esophageal malignant lesions in the Chinese population

 Last Update: 2022-05-14
 Source: Internet
 Author: User

Tags

dnn model

active control

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, eClinicalMedicine , a sub-journal of The Lancet, published a research report titled " Update and validation of a diagnostic model to identify prevalent malignant lesions in esophagus in general population " by Prof.

Esophageal cancer is a high-incidence tumor in China, and more than half of the world's new cases occur in China

In 2017, Ke Yang's research group published the first "Diagnostic Model of Presence Risk of Esophageal Malignant Lesions (Ver 1.

The analysis shows that in a large natural population cohort, the new version of the diagnostic model proposed in this study can predict the risk of existing esophageal malignant lesions

Discrimination performance of diagnostic model for the current state of esophageal malignant lesions

The enrichment performance of the diagnostic model for high-risk populations under different criteria

For nearly 20 years, Ke Yang's research group has been deeply involved in the prevention and treatment of rural areas in high-incidence areas of esophageal cancer in China, always focusing on the key bottlenecks in the etiology and precise prevention and treatment of esophageal cancer, and established "esophageal malignant tumors" suitable for community screening and clinical opportunistic screening, respectively.

Team photo

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.